Purification and characterization of recombinant human mineralocorticoid receptor

Molecular and Cellular Endocrinology

Volumn 302, Issue 1, 2009, Pages 81-85

  Clyne, Colin D ^a   Chang, Ching Yi ^b   Safi, Rachid ^b   Fuller, Peter J ^a   McDonnell, Donald P ^b   Young, Morag J ^a  

^a HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Baculoviral expression; Mineralocorticoid receptor; Protein purification

Indexed keywords

ALDOSTERONE; AVIDIN; HYDROCORTISONE; MINERALOCORTICOID RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; RECOMBINANT HUMAN MINERALOCORTICOID RECEPTOR; RECOMBINANT RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BIOTINYLATION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG ANALYSIS; DRUG PURIFICATION; DRUG STRUCTURE; HUMAN; HUMAN CELL; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; BACULOVIRIDAE; BLOTTING, WESTERN; CELL LINE, TUMOR; HUMANS; INSECTS; LIVER; RECEPTORS, MINERALOCORTICOID; RECOMBINANT PROTEINS;

EID: 60549093709     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2008.11.030     Document Type: Article

References (26)

1. Alnemri E.S., and Litwack G. The steroid binding domain influences intracellular solubility of the baculovirus overexpressed glucocorticoid and mineralocorticoid receptors. Biochemistry 32 (1993) 5387-5393
2. Alnemri E.S., Maksymowych A.B., Robertson N.M., and Litwack G. Overexpression and characterization of the human mineralocorticoid receptor. J. Biol. Chem. 266 (1991) 18072-18081
3. Arriza J.L., Weinberger C., Cerelli G., Glaser T.M., Handelin B.L., Housman D.E., and Evans R.M. Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science 237 (1987) 268-275
4. Bapat A.R., and Frail D.E. Full-length estrogen receptor alpha and its ligand-binding domain adopt different conformations upon binding ligand. J. Steroid Biochem. Mol. Biol. 86 (2003) 143-149
5. Binart N., Lombes M., Rafestin-Oblin M.E., and Baulieu E.E. Characterization of human mineralocorticosteroid receptor expressed in the baculovirus system. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 10681-10685
6. Bledsoe R.K., Madauss K.P., Holt J.A., Apolito C.J., Lambert M.H., Pearce K.H., Stanley T.B., Stewart E.L., Trump R.P., Willson T.M., and Williams S.P. A ligand-mediated hydrogen bond network required for the activation of the mineralocorticoid receptor. J. Biol. Chem. 280 (2005) 31283-31293
7. Bureik M., Bruck N., Hubel K., and Bernhardt R. The human mineralocorticoid receptor only partially differentiates between different ligands after expression in fission yeast. FEMS Yeast Res. 5 (2005) 627-633
8. Duffy S., Tsao K.L., and Waugh D.S. Site-specific, enzymatic biotinylation of recombinant proteins in Spodoptera frugiperda cells using biotin acceptor peptides. Anal. Biochem. 262 (1998) 122-128
9. Fagart J., Huyet J., Pinon G.M., Rochel M., Mayer C., and Rafestin-Oblin M.E. Crystal structure of a mutant mineralocorticoid receptor responsible for hypertension. Nat. Struct. Mol. Biol. 12 (2005) 554-555
10. Fuller P.J., and Young M.J. Mechanisms of mineralocorticoid action. Hypertension 46 (2005) 1227-1235
11. Galigniana M.D. Stability study on renal type I mineralocorticoid receptor. Life Sci. 59 (1996) 511-521
12. Geller D.S., Farhi A., Pinkerton N., Fradley M., Moritz M., Spitzer A., Meinke G., Tsai F.T., Sigler P.B., and Lifton R.P. Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy. Science 289 (2000) 119-123
13. Gomez-Sanchez C.E., de Rodriguez A.F., Romero D.G., Estess J., Warden M.P., Gomez-Sanchez M.T., and Gomez-Sanchez E.P. Development of a panel of monoclonal antibodies against the mineralocorticoid receptor. Endocrinology 147 (2006) 1343-1348
14. Huyet J., Pinon G.M., Fay M.R., Fagart J., and Rafestin-Oblin M.E. Structural basis of spirolactone recognition by the mineralocorticoid receptor. Mol. Pharmacol. 72 (2007) 563-571
15. Knutti D., Kaul A., and Kralli A. A tissue-specific coactivator of steroid receptors, identified in a functional genetic screen. Mol. Cell Biol. 20 (2000) 2411-2422
16. Lange C.A., Shen T., and Horwitz K.B. Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteasome. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 1032-1037
17. Li Y., Suino K., Daugherty J., and Xu H.E. Structural and biochemical mechanisms for the specificity of hormone binding and coactivator assembly by mineralocorticoid receptor. Mol. Cell 19 (2005) 367-380
18. Mettu N.B., Stanley T.B., Dwyer M.A., Jansen M.S., Allen J.E., Hall J.M., and McDonnell D.P. The nuclear receptor-coactivator interaction surface as a target for peptide antagonists of the peroxisome proliferator-activated receptors. Mol. Endocrinol. 21 (2007) 2361-2377
19. Pascual-Le T.L., and Lombes M. The mineralocorticoid receptor: a journey exploring its diversity and specificity of action. Mol. Endocrinol. 19 (2005) 2211-2221
20. Pitt B., Reichek N., Willenbrock R., Zannad F., Phillips R.A., Roniker B., Kleiman J., Krause S., Burns D., and Williams G.H. Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study. Circulation 108 (2003) 1831-1838
21. Pitt B., Remme W., Zannad F., Neaton J., Martinez F., Roniker B., Bittman R., Hurley S., Kleiman J., and Gatlin M. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N. Engl. J. Med. 348 (2003) 1309-1321
22. Pitt B., Zannad F., Remme W.J., Cody R., Castaigne A., Perez A., Palensky J., and Wittes J. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N. Engl. J. Med. 341 (1999) 709-717
23. Rogerson F.M., and Fuller P.J. Interdomain interactions in the mineralocorticoid receptor. Mol. Cell Endocrinol. 200 (2003) 45-55
24. Schatz P.J. Use of peptide libraries to map the substrate specificity of a peptide-modifying enzyme: a 13 residue consensus peptide specifies biotinylation in Escherichia coli. Biotechnology (N. Y.) 11 (1993) 1138-1143
25. Sutanto W., and de Kloet E.R. Mineralocorticoid receptor ligands: biochemical, pharmacological, and clinical aspects. Med. Res. Rev. 11 (1991) 617-639
26. Viengchareun S., Le M.D., Martinerie L., Munier M., Pascual-Le T.L., and Lombes M. The mineralocorticoid receptor: insights into its molecular and (patho)physiological biology. Nucl. Recept. Signal 5 (2007) e012